Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial

Overview of attention for article published in The Lancet, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 58 news outlets
blogs: 6 blogs
policy: 1 policy source
twitter: 1174 X users
patent: 1 patent

facebook: 12 Facebook pages
reddit: 3 Redditors
guideline: 1 clinical guideline source
bluesky: 5 Bluesky users

Readers on

mendeley: 572 Mendeley

So far, Altmetric has seen 60 news stories from 58 outlets.

Cette gynécologue est formelle : "plus de 99 % de cas de cancer du col de l’utérus sont dus à cette cause n°1"

Aufeminin, 16 Jan 2026

Du 26 au 31 janvier 2026 se tient la semaine de prévention du cancer du col de l’utérus.

News story from Top Santé on Wednesday 26 February 2025

Top Santé, 26 Feb 2025

“Más del 99% de los casos se deben a esta causa número 1”, advierte un ginecólogo

Espanol.news, 10 Jan 2025

La semana de prevención del cáncer de cuello uterino se celebra del 23 al 29 de enero de 2025.

L'efficacité du vaccin contre le papillomavirus

La Recherche, 21 Feb 2024

Dans la population mondiale, environ 80 % des hommes et femmes sexuellement actifs entrent en contact avec un papillomavirus (HPV…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 56 additional news stories.